Atea Pharmaceuticals, Inc.

AVIR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$5.33+1.33%

2026-09-18

Financials

Valuation Metrics

Atea Pharmaceuticals, Inc.'s Market Cap is $427M. At end of 2025 it was $279M. Ranked #2853 of 3,121 in US market (top 91%), #1263 of 1,463 on NASDAQ (top 86%), #229 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$427M	US#2,853/3,121 Sec#229/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-165M	US—/3,121 Sec—/266
Total Assets	$232M	US#2,971/3,121 Sec#239/266
Net Assets	$204M	US#2,678/3,121 Sec#193/266
Value
P/B	2.09x	US#1,290/3,121 Sec#54/266
FCF Yield	-35.65%	US—/3,121 Sec—/266
Profitability
ROE	-80.96%	US#2,773/3,121 Sec#194/266
ROA	-71.16%	US#3,036/3,121 Sec#241/266
Financial Health
Debt Ratio	13.78%	US#156/3,121 Sec#64/266
Total Debt	$424000.00	US#3,006/3,121 Sec#257/266
FCF	$-152M	US#2,720/3,121 Sec#178/266
Cash	$77M	US#2,374/3,121 Sec#196/266
Current Ratio	8.13x	US#315/3,121 Sec#97/266
Performance
1Y Return	79.46%	US#293/3,121 Sec#76/266
1M Return	-4.65%	US#994/3,121 Sec#98/266
From 52W High	-17.36%	US#1,391/3,121 Sec#99/266
1Y MDD	-33.33%	US#1,654/3,121 Sec#108/266
Trading
Volume	485,991 shares	US#2,465/3,121 Sec#238/266
Trading Value	$3M	US#2,966/3,121 Sec#255/266
Per Share
EPS	$-2.07	US—/3,121 Sec—/266
BPS	$2.55	US#2,534/3,121 Sec#169/266